Evolent Health, Inc.
Evolent Health, Inc. (EVH) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · EVH · as of Jun 8, 2026
Key Statistics
Explore Evolent Health, Inc. Data
evh stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 29 · Buy rate: 79.3%
The EVH analyst consensus is Buy, based on ratings from 29 Wall Street analysts over the past 3 months. The average 12-month price target is $6.38, representing +51.18% upside from the current price of $4.22.
Competitors & Peers
evh competitorsEVH
AMN
AVBP
BFLY
HSTM
KURAStock Performance
Full HistoryAbout Evolent Health, Inc.
Evolent Health, Inc. a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two …
what is evolent health, inc. · evh stock overview · evolent health, inc. company profile · who is evolent health, inc. ceo · evh NYSE · evolent health, inc. headquarters · evolent health, inc. business segments
About Stock Overview & Key Data
Evolent Health, Inc. (EVH) is a Healthcare company in the Medical - Healthcare Information Services industry, listed on NYSE since Jun 5, 2015. As of the latest trading session, EVH stock price is $4.22, with a market capitalization of $474.7M. The stock has returned -50.24% over the past 12 months and +5.50% year-to-date.
According to 29 Wall Street analysts, the consensus rating for Evolent Health, Inc. stock is Buy, with an average 12-month price target of $6.38. In fiscal year 2025, Evolent Health, Inc. reported revenue of $1.9B and net income of -$534.5M. For detailed data — including Evolent Health, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Evolent Health, Inc. (EVH) stock price is $4.22. The stock is traded on NYSE under the ticker symbol EVH. The 52-week range is $2.10 – $12.06.